Clinical trial
A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic…
NCT00191412 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00191412 |
|---|---|
| Title | A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the Liver |
| Official title | Phase II Study of Single-Agent Alimta in the Treatment of Patients With Advanced and Metastatic Hepatoma |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Liver Cancer |
| Intervention type | Drug |
| Interventions | Pemetrexed |
| Enrollment | 41 |
| Start date | Jan 1, 2005 |
| Completion | Mar 1, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | Nov 20, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: